NervGen Pharma (9UA.STU) Q3 2026 Earnings

12AugConfirmed
Q2 2026
Next
-0.06
-0.05
-0.03
-0.01

Details

Expected EPS
-0.06350086624
Actual EPS
N/A
Surprise EPS
0.06
Surprise Percent
+100%

Description

NervGen Pharma (9UA.STU) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts